As of 2025-09-15, the Relative Valuation of Arbutus Biopharma Corp (ABUS) is (3.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.46 USD, the upside of Arbutus Biopharma Corp based on Relative Valuation is -184.1%.
The range of the Relative Valuation is (3.01) - (4.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.1x | 13.3x |
| Forward P/E multiples | 7.4x - 16.6x | 13.2x |
| Fair Price | (3.01) - (4.28) | (3.75) |
| Upside | -167.5% - -196.1% | -184.1% |
| Date | P/E |
| 2025-09-11 | -17.31 |
| 2025-09-10 | -16.32 |
| 2025-09-09 | -15.30 |
| 2025-09-08 | -14.45 |
| 2025-09-05 | -14.84 |
| 2025-09-04 | -14.17 |
| 2025-09-03 | -13.89 |
| 2025-09-02 | -13.50 |
| 2025-08-29 | -13.11 |
| 2025-08-28 | -12.97 |
| 2025-08-27 | -12.90 |
| 2025-08-26 | -12.90 |
| 2025-08-25 | -12.37 |
| 2025-08-22 | -12.69 |
| 2025-08-21 | -12.65 |
| 2025-08-20 | -12.33 |
| 2025-08-19 | -12.33 |
| 2025-08-18 | -11.94 |
| 2025-08-15 | -11.89 |
| 2025-08-14 | -11.91 |
| 2025-08-13 | -11.91 |
| 2025-08-12 | -12.01 |
| 2025-08-11 | -11.84 |
| 2025-08-08 | -12.01 |
| 2025-08-07 | -12.01 |
| 2025-08-06 | -12.26 |
| 2025-08-05 | -12.05 |
| 2025-08-04 | -11.80 |
| 2025-08-01 | -11.55 |
| 2025-07-31 | -11.59 |
| 2025-07-30 | -11.66 |
| 2025-07-29 | -11.66 |
| 2025-07-28 | -11.84 |
| 2025-07-25 | -11.38 |
| 2025-07-24 | -11.45 |
| 2025-07-23 | -11.41 |
| 2025-07-22 | -11.13 |
| 2025-07-21 | -11.10 |
| 2025-07-18 | -11.06 |
| 2025-07-17 | -11.10 |
| 2025-07-16 | -11.06 |
| 2025-07-15 | -11.06 |
| 2025-07-14 | -11.45 |
| 2025-07-11 | -11.20 |
| 2025-07-10 | -11.59 |
| 2025-07-09 | -11.80 |
| 2025-07-08 | -11.24 |
| 2025-07-07 | -11.10 |
| 2025-07-03 | -11.45 |
| 2025-07-02 | -11.27 |